Veeva Commercial Pulse Improves Segmentation and Targeting with Brick-Level HCP Access Data for 21 Countries
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Citi Reiterates Buy Rating on Veeva Systems (VEEV)
March 6, 2025 10:40 AM ESTCiti analyst Tyler Radke reiterated a Buy rating and $307.00 price target on Veeva Systems (NYSE: VEEV).
The analyst comments "The Q4 print featured a strong beat on key metrics with normalized billings beating by 5 pts while subscription/op margins were ahead by... More
Veeva Systems (VEEV) PT Raised to $217 at Truist Securities
March 6, 2025 6:47 AM ESTTruist Securities analyst Joe Meares raised the price target on Veeva Systems (NYSE: VEEV) to $217.00 (from $210.00) while maintaining a Hold rating.
The analyst comments "VEEV reported FY4Q25 results ahead of consensus. Along with the release, the company issued FY26 guide... More
Veeva Systems (VEEV) PT Raised to $250 at Evercore ISI
March 6, 2025 6:18 AM ESTEvercore ISI analyst Kirk Materne raised the price target on Veeva Systems (NYSE: VEEV) to $250.00 (from $245.00) while maintaining a In Line rating.
The analyst comments "VEEV delivered strong 4Q25 results with total revenue of $720.9mn (+14% y/y), above our/street estimates of $697.2mn/$699mn and EPS of $1.74 well above our/Street estimates of $1.57/$1.58. Q4 normalized billings was also up 17% y/y to $1.24bn, due to strong business execution and higher than expected proportion of annual billing terms. FY26... More
